Wegovy® in a Pill Now Available in Iowa

For years, GLP-1 medications like Wegovy® have helped patients achieve meaningful weight loss, but injections were the only option. That changed in late 2025.

As of January 2026, the first oral GLP-1 medication approved specifically for weight loss is now available nationwide, including right here in Iowa.

The new Wegovy® pill (oral semaglutide) offers effective weight management in a once-daily tablet, giving patients more flexibility, convenience, and access than ever before.

At Iowa Weight Loss Specialists, our providers see this as a major step forward in patient care.

Why the Wegovy® Pill Matters for Patients

For years, many patients delayed treatment because they didn’t want injections or struggled with access and cost. According to Jon Hardersen, PA, the new oral option changes that:

“The availability of oral GLP-1s should increase access to care. Although the cash pay price is only slightly lower, having this option without the inconvenience of injectable medication is a big win!”

By offering the same active ingredient as injectable Wegovy® in pill form, this medication removes a major obstacle for patients seeking effective weight loss treatment without weekly shots.

What Is the Wegovy® Pill and How Does It Work?

The Wegovy® pill contains semaglutide, a GLP-1 receptor agonist that works by:

• Reducing appetite signals in the brain
• Helping you feel full sooner
• Slowing stomach emptying
• Supporting healthier eating patterns

This is the same proven science behind injectable Wegovy®, now delivered in a once-daily tablet.

Dr. Todd Eibes, MD, FACS, explains why this matters for long-term obesity care:

“The oral GLP-1 medications are going to continue to expand the options we have to treat obesity. The big advantage is going to be that they are more affordable and convenient.”

FDA Approval and Availability in 2026

• FDA approved: December 22, 2025
• Available nationwide: January 2026
• First and only oral GLP-1 approved for weight loss

The Wegovy® pill is now available through 70,000+ U.S. pharmacies. Novo Nordisk has invested heavily in U.S.-based manufacturing to help meet demand and avoid shortages seen with earlier injectable GLP-1 medications.

Who Is the Wegovy® Pill Approved For?

The Wegovy® pill is approved for adults who:

• Have obesity (BMI ≥ 30), or
• Have an overweight (BMI ≥ 27) with at least one weight-related condition, such as high blood pressure or high cholesterol

It is prescribed alongside:

• A reduced-calorie diet
• Increased physical activity

This makes it a long-term weight management tool, not a quick fix.

How Effective Is the Wegovy® Pill for Weight Loss?

Clinical trials show that the Wegovy® pill delivers strong, sustained weight loss.

Average Results

• 13.6%–17% average weight loss over 64 weeks
• Results comparable to injectable Wegovy®
• Significantly more effective than a placebo

These outcomes make it one of the most effective oral GLP-1 weight loss medications ever approved.

Cost and Insurance Coverage

Self-Pay Pricing

• $149/month for starter doses
• $299/month for higher maintenance doses
• Generally lower than injectable Wegovy®, which often exceeds $300–$350/month without insurance

With Insurance

• Some patients may pay $25 or less per month
• Coverage varies by plan

Lower production and storage costs help make the pill more accessible over time.

Side Effects and Safety Considerations

Common Side Effects

• Nausea
• Vomiting
• Diarrhea
• Constipation

These are similar to injectable GLP-1 medications and often improve as the body adjusts to the drug.

Important Safety Note

The Wegovy® pill carries the same boxed warning as injectable GLP-1s regarding the potential risk of thyroid C-cell tumors and is not appropriate for all patients.

Wegovy® Pill vs. Injection: Which Is Right for You?

The biggest difference is how the medication fits into daily life:

• Pill: Daily dosing, no needles, flexible control
• Injection: Weekly dosing, longer-lasting effects

As Lynzy Devary, ARNP, FNP-C, explains:

“Having an effective option in pill form offers patients more flexibility, improved affordability, and greater control with daily dosing—all without the need for injections. This expands access and allows us to better tailor treatment plans to each patient's lifestyle and needs.”

For some patients, a daily pill is empowering. Others may still prefer a weekly injection. The right choice depends on lifestyle, tolerance, cost, and medical history.

Explore Your Options With Iowa Weight Loss Specialists

At Iowa Weight Loss Specialists, we provide expert, evidence-based care using the latest advancements in weight management, including the new Wegovy® pill.

If you’re ready to explore a more convenient, effective approach to weight loss, schedule a consultation today. Our medical team will help you decide whether oral GLP-1 therapy is right for you and create a personalized plan that supports lasting results.